Adjunctive everolimus therapy is safe and effective for reducing the frequency of seizures in pediatric patients with tuberous sclerosis complex (TSC), according to a post-hoc analysis of a phase 3, prospective, randomized, double-blind, placebo-controlled study published in the May 23 online edition of The Lancet Child & Adolescent Health. Epileptic seizures in TSC are […]
Epileptic seizures strike with little warning and nearly one third of people living with epilepsy are resistant to treatment that controls these attacks. More than 65 million people worldwide are living with epilepsy.
A lack of support staff, low morale and bad management are being cited by a government watchdog report as reasons for problems that the Social Security Administration (SSA) is having in providing adequate customer service to the millions of individuals who rely on its benefits. For years, the SSA has faced criticisms for the […]
A new innovation in brain scanner technology promises high-resolution neuroimaging in subjects without restricting their head and body movements. Neurons are specialized cells that are designed to generate electrochemical signals. These signals are the currency used to transmit information across the body. Neurons connect the brain, spinal cord, and each nook and cranny of our […]
Research could inform development of individualized stimulation protocols for neuropsychiatric disorders A study of epilepsy patients with implanted electrodes provides an unprecedented view of the changes in brain activity created by electrical stimulation. These findings, published in JNeurosci, have the potential to improve noninvasive stimulation approaches toward the treatment of neuropsychiatric disorders. Repetitive […]
Researchers at the University of California, Irvine School of Medicine have discovered the first example of a novel mode of neurotransmitter-based communication. The discovery, published in Nature Communications, challenges current dogma about mechanisms of signaling in the brain, and uncovers new pathways for developing therapies for disorders like epilepsy, anxiety and chronic pain.